$20 Million drug plant opens in Mukono, Uganda

The Ugandan pharmaceutical industry is becoming one of most lucrative businesses. The latest entrant in the manufacturing sector is the newly-established $20 million processing plant owned by Abacus Parenterals Drugs Ltd, according to a report from the local news service, Business Vision.
severe stroke, trauma, dehydration, loss of blood, vomiting and various critically ill patients. The factory also produces Water For Injection, eye and ear drops. The development comes a year after the Luzira-based Quality Chemicals Pharmaceuticals started manufacturing anti-retroviral drugs.

Parenterals drugs are mainly prescribed to patients with ailments related to
According to the proprietors of Abacus, the facility is the only one of its kind in East Africa and probably the fourth in Africa. The region has mostly been importing parenteral drugs from India and France. "This facility seamlessly integrates hi-tech engineering services into the building designs, materials and finishes are carefully chosen to maintain acceptable cleanliness standards. It is designed to meet the Current Good manufacturing practice requirements," the company managing director, Ramesh Babu, told Business Vision.

"The establishment of this plant will save the target countries' from spending money in transport costs from overseas and fetch Uganda a considerable rate of foreign exchange earnings since the region will depend on her. It currently employs over 300 people," Mr Ramesh added.

The company belongs to a chain including Abacus Pharma (Africa) Ltd, which imports and distributes human drugs and varied pharmaceutical and surgical equipments worth $15 million annually.